205 related articles for article (PubMed ID: 17962944)
21. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
22. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S; Forloni M; Cifaldi L; Antonucci C; Citti A; Boldrini R; Pezzullo M; Castellano A; Russo V; van der Bruggen P; Giacomini P; Locatelli F; Fruci D
PLoS One; 2012; 7(10):e46928. PubMed ID: 23071666
[TBL] [Abstract][Full Text] [Related]
23. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
[TBL] [Abstract][Full Text] [Related]
24. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
[TBL] [Abstract][Full Text] [Related]
25. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
26. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
27. Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.
David E; Sinha R; Chen J; Sun SY; Kaufman JL; Lonial S
Clin Cancer Res; 2008 Aug; 14(16):5090-8. PubMed ID: 18698026
[TBL] [Abstract][Full Text] [Related]
28. Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.
Demotte N; Stroobant V; Courtoy PJ; Van Der Smissen P; Colau D; Luescher IF; Hivroz C; Nicaise J; Squifflet JL; Mourad M; Godelaine D; Boon T; van der Bruggen P
Immunity; 2008 Mar; 28(3):414-24. PubMed ID: 18342010
[TBL] [Abstract][Full Text] [Related]
29. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.
de Vries JF; von dem Borne PA; van Luxemburg-Heijs SA; Heemskerk MH; Willemze R; Falkenburg JH; Barge RM
Haematologica; 2007 Dec; 92(12):1671-8. PubMed ID: 18055991
[TBL] [Abstract][Full Text] [Related]
30. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
31. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
Gross N; Favre S; Beck D; Meyer M
Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
[TBL] [Abstract][Full Text] [Related]
32. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
[TBL] [Abstract][Full Text] [Related]
33. Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack.
Bergmann-Leitner ES; Abrams SI
Cancer Immunol Immunother; 2000 Jul; 49(4-5):193-207. PubMed ID: 10941902
[TBL] [Abstract][Full Text] [Related]
34. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.
Facchetti P; Prigione I; Ghiotto F; Tasso P; Garaventa A; Pistoia V
Cancer Immunol Immunother; 1996 Mar; 42(3):170-8. PubMed ID: 8640845
[TBL] [Abstract][Full Text] [Related]
35. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
Morandi F; Chiesa S; Bocca P; Millo E; Salis A; Solari M; Pistoia V; Prigione I
Neoplasia; 2006 Oct; 8(10):833-42. PubMed ID: 17032500
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex-restricted lysis of neuroblastoma cells by autologous cytotoxic T lymphocytes.
Sarkar AK; Burlingame SM; Zang YQ; Dulai V; Hicks MJ; Strother DR; Nuchtern JG
J Immunother; 2001; 24(4):305-11. PubMed ID: 11565832
[TBL] [Abstract][Full Text] [Related]
37. A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma.
Ziegler MM; Ishizu H; Nagabuchi E; Takada N; Arya G
Cancer; 1997 May; 79(9):1757-66. PubMed ID: 9128993
[TBL] [Abstract][Full Text] [Related]
38. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Pule MA; Savoldo B; Myers GD; Rossig C; Russell HV; Dotti G; Huls MH; Liu E; Gee AP; Mei Z; Yvon E; Weiss HL; Liu H; Rooney CM; Heslop HE; Brenner MK
Nat Med; 2008 Nov; 14(11):1264-70. PubMed ID: 18978797
[TBL] [Abstract][Full Text] [Related]
39. Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.
Cordeau M; Belounis A; Lelaidier M; Cordeiro P; Sartelet H; Herblot S; Duval M
PLoS One; 2016; 11(10):e0164401. PubMed ID: 27716850
[TBL] [Abstract][Full Text] [Related]
40. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]